Pink Sheet is part of the Business Intelligence Division of Informa PLC

This site is operated by a business or businesses owned by Informa PLC and all copyright resides with them. Informa PLC’s registered office is 5 Howick Place, London SW1P 1WG. Registered in England and Wales. Number 8860726.

This copy is for your personal, non-commercial use. For high-quality copies or electronic reprints for distribution to colleagues or customers, please call +44 (0) 20 3377 3183

Printed By

New US Compassionate Use Tool Would Need Support Of Drug Makers

This article was originally published in SRA

Executive Summary

The US Food and Drug Administration and not-for-profit organization, the Reagan-Udall Foundation, are exploring a proposed tool that could make it easier for physicians and patients seeking access to unapproved drugs by providing a central repository of information about biopharma manufacturers' policies and points of contact1,2.

Advertisement

Related Content

NIH Funding Component of 21st Century Cures May Get White House Boost
'Right To Try' Or 'Right To Ask'? Hearing Spotlights Adverse Events As Key Barrier To Expanded Access
Advertisement
UsernamePublicRestriction

Register